
PROCEPT BioRobotics is a biotechnology company that develops autonomous tissue removal robots for the treatment of benign prostatic hyperplasia. Read more
PROCEPT BioRobotics is a biotechnology company that develops autonomous tissue removal robots for the treatment of benign prostatic hyperplasia. Read more
PROCEPT BioRobotics is a biotechnology company that develops autonomous tissue removal robots for the treatment of benign prostatic hyperplasia. Read more
President & CEO
Reza Zadno
Urologix is PROCEPT BioRobotics's biggest rival. Urologix was founded in Minneapolis, Minnesota} in 1991. Like PROCEPT BioRobotics, Urologix also competes in the Health Care Equipment sector. Compared to PROCEPT BioRobotics, Urologix generates $11M more revenue.
No recent acquisitions found related to PROCEPT BioRobotics
Since PROCEPT BioRobotics was founded in 2009, it has participated in 6 rounds of funding. In total PROCEPT BioRobotics has raised $263.8M. PROCEPT BioRobotics' last funding round was on Jul 2020 for a total of $77.0M
Since PROCEPT BioRobotics was founded in 2009, it has participated in 6 rounds of funding. In total PROCEPT BioRobotics has raised $263.8M. PROCEPT BioRobotics' last funding round was on Jul 2020 for a total of $77.0M
No recent investments found related to PROCEPT BioRobotics